Quarterly report pursuant to Section 13 or 15(d)

Equity (Details) - Schedule of stock-based compensation expense

v3.22.1
Equity (Details) - Schedule of stock-based compensation expense - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Mar. 31, 2022
Mar. 31, 2021
Schedule of stock-based compensation expense [Abstract]        
Research and Development $ 1,327 $ 1,011 $ 4,275 $ 2,953
General and Administrative 1,179 980 3,479 3,131
Total $ 2,506 $ 1,991 $ 7,754 $ 6,084